Bicara Therapeutics (BCAX) EPS (Diluted) (2023 - 2026)

Bicara Therapeutics (BCAX) EPS (Diluted) (2023 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 0.00
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 0.15
4 NuCana 279.75 Bn 279.75 Bn - -368,323.02
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 4.02
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 6.75
7 Belite Bio 62.51 Bn 62.51 Bn - 0.00
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 7.33
9 Revolution Medicines 37.78 Bn 37.78 Bn - -2.29
10 Bicara Therapeutics 1.68 Bn 1.68 Bn - -0.93

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.93
Dec 31, 2025 0.00
Sep 30, 2025 -0.67
Jun 30, 2025 -0.50
Mar 31, 2025 -0.68
Dec 31, 2024 0.00
Sep 30, 2024 -1.60
Jun 30, 2024 -19.01
Mar 31, 2024 -18.94
Dec 31, 2023 -0.02
Sep 30, 2023 -38.23